MJ Nutra Recalls Champignons et Adaptogènes Due to Ingredient Concentration Discrepancies
According to the U.S. Census Bureau's American Community Survey (ACS) 5-year estimates, the CDC PLACES population-level health analysis, and the CMS Hospital Compare quality data, Areazine publishes editorial articles drawing on more than 19,000 U.S. city profiles. See our methodology for full source attribution and refresh cadence.
MJ Nutra has issued a recall for a specific lot of Champignons et Adaptogènes powder because the concentration of certain ingredients does not match the product label.
What this Health Canada recall tells you, and what most readers miss
This notice was issued by Health Canada on February 27, 2026 and geographically references Canada. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken — "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to — Product & Food Recalls — determines the regulatory framework behind it, which shapes what remedies (refunds, replacements, recalls, evacuations) are available to affected individuals and who holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly Health Canada detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action — a single localized Health Canada recall is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.
For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (recall, product-safety, health-canada, HealthProduct) map to related alerts in the same area of risk — browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.
What Happened
MJ Nutra has initiated a recall for one lot of its health product, Champignons et Adaptogènes. The recall was issued because the affected lot contains concentrations of certain ingredients that differ from the concentrations listed on the product label. This discrepancy was identified during a review of the product's lot-specific data.
Which Products Are Affected
The recall specifically impacts the following product:
- Brand: MJ Nutra
- Product Name: Champignons et Adaptogènes
- Market Authorization (NPN): 80139467
- Dosage Form: Powder
- Affected Lot: 225107
- Labelled Ingredients: Astragalus membranaceus (472.5 mg), Eleutherococcus senticosus (940.0 mg), Ganoderma lucidum (200.0 mg), Hericium erinaceus (610.0 mg), Lepidium meyenii (1.89 g), Lycium barbarum (610.0 mg), Paecilomyces hepialid (710.0 mg), Panax ginseng (140.0 mg), Phyllanthus emblica (140.0 mg), Rhodiola rosea (410.0 mg), and Withania somnifera (2.65 g).
What You Should Do
Consumers are advised to verify if their product belongs to the affected lot (225107). Health Canada recommends consulting a healthcare provider before discontinuing the use of the product or if you have any health concerns related to its consumption.
For questions regarding the recall, consumers can contact MJ Nutra at 1335 rue René-Descartes, Saint-Bruno, QC, J3V 0B7. Any health product-related side effects or safety complaints should be reported directly to Health Canada.
Why This Matters
When the actual concentration of ingredients in a health supplement differs from the label, consumers may unknowingly ingest incorrect dosages. This can lead to unexpected side effects or a lack of intended therapeutic benefit.
Source
For more information, visit the official Health Canada recall notice.
Original source: Health Canada Official Notice ↗
Related Product & Food Recalls
All Product & Food Recalls →Frequently Asked Questions
Common questions about this Health Canada recall.
What is this Health Canada recall about? ▾
Which agency issued this alert? ▾
How severe is this alert? ▾
What area is affected? ▾
Where can I find more Product & Food Recalls updates? ▾
Primary source data
EPA Outdoor Air Quality Data
Federal monitoring network — every measurement we report
AirNow (EPA / NOAA)
Real-time AQI for every monitored U.S. location
National Weather Service
Active watches, warnings, and advisories — NOAA
CDC Air Quality & Health
Health-impact reference behind every AQI category